David A. Siegel Aura Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 14,700 shares of AURA stock, worth $134,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,700
Previous 35,400
58.47%
Holding current value
$134,358
Previous $267,000
51.31%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$63.3 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$53 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$44.6 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$27.8 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$27.5 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $268M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...